mdl 19660 has been researched along with pargyline in 1 studies
Studies (mdl 19660) | Trials (mdl 19660) | Recent Studies (post-2010) (mdl 19660) | Studies (pargyline) | Trials (pargyline) | Recent Studies (post-2010) (pargyline) |
---|---|---|---|---|---|
5 | 0 | 0 | 2,811 | 27 | 295 |
Protein | Taxonomy | mdl 19660 (IC50) | pargyline (IC50) |
---|---|---|---|
Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 1.535 | |
Amine oxidase [flavin-containing] A | Homo sapiens (human) | 2.8888 | |
Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.5031 | |
Renin | Callithrix jacchus (white-tufted-ear marmoset) | 2.6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dudley, MW; Kane, JM; Miller, FP; Sorensen, SM | 1 |
1 other study(ies) available for mdl 19660 and pargyline
Article | Year |
---|---|
2,4-Dihydro-3H-1,2,4-triazole-3-thiones as potential antidepressant agents.
Topics: Animals; Antidepressive Agents; Desipramine; gamma-Aminobutyric Acid; Male; Mice; Monoamine Oxidase Inhibitors; Norepinephrine; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Triazoles | 1988 |